Meet Marc Presler, a member of Certara QSP’s Team! Marc has leveraged deep expertise in fundamental biology and quantitation to support over 70 drug programs. He sees models as powerful tools that help integrate evidence to improve decision-making in drug development.

His contributions have ranged from clinical trial design, first-in-human dose projections, to initial concept design, working with collaborators spanning large pharma to pre-seed biotechs.

Marc is particularly excited about bringing biosimulation insights into the earliest stages of drug discovery. He is currently working on developing the “industrial” capabilities that will allow the analysis of discovery pipelines at scale:

What if biosimulation were used to ensure favorable pharmacology for every new drug concept at the beginning of a program?